Home / Medical Devices / Respiratory Inhalers Market By Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disorder, Pulmonary Arterial Hypertension, Cystic Fibrosis), By Technology (Digital, Manual) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Respiratory Inhalers Market By Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disorder, Pulmonary Arterial Hypertension, Cystic Fibrosis), By Technology (Digital, Manual) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Published: Nov 2017 | Report Code: 58860-11-17

Respiratory inhalers are used to administer an extensive range of medications such as beta-agonists, anticholinergic, corticosteroids and certain antibiotics. Respiratory inhalers are used to provide relief of symptoms in various respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, bronchitis and cystic fibrosis. In such respiratory conditions both mild and severe symptoms occur such as coughing, shortness of breath, chest congestion, respiratory discomfort and even death in extreme cases. Thus it becomes important to relieve the symptoms immediately which is accomplished by the use of inhalers.

Drug administration by inhalers is most widely prescribed as it requires lesser doses to give quick relief thus reducing the risk of side effects unlike oral medications. The rise in prevalence of the aforementioned respiratory conditions and the continuous rise in environmental pollution has led to the rise in growth of respiratory inhaler market in the current and forecast period, 2017-2025.

The current study report on respiratory inhalers provides an in depth insight on the market trends and dynamics. The report includes market estimations and forecast data for the period 2017-2025. The market has been analyzed and studied into various segments which are as follows:

  • Type
    • Dry powder Inhalers
    • Metered Dose Inhalers
      • Pressurized
      • Breath-actuated
      • Non-pressurized
    • Nebulizers
      • Jet nebulizer
      • Mesh nebulizer
      • Ultrasonic nebulizer
  • Application
    • Asthma
    • Chronic Obstructive Pulmonary Disorder
    • Pulmonary Arterial Hypertension
    • Cystic Fibrosis
    • Others
  • Technology
    • Digital
    • Manual

The respiratory inhalers market have also been studied across geographies. For the purpose of this study the respiratory inhalers market is segmented based on geographies as follows:

  • North America
    • USA
    • Canada
  • Europe
    • U.K
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market evaluation and forecast analysis for the above mentioned segments for the duration 2015-2025 has been incorporated in this report. The values are have been represented in terms of US$ Mn. Furthermore, the respective growth rates for each of the mentioned segments has also been inculcated with 2016 as the base year.

This report also comprehends qualitative insights with respect to market restraints, opportunities and drivers. These insights provides an overview of the entire market and would assist emerging players to strategize their product growth within this market. A competitive landscape depicting market position of the industrial players has also been incorporated win this report. Company profiles of each of the industrial leaders with respect to financial performance, product portfolio, current market trends and general information has been incorporated. The profiles of major industrial leaders incorporated are Boehringer Ingelheim GmbH, Astra Zeneca, PARI Medical Holding, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., GlaxoSmithKline plc, Beximco Pharmaceuticals Ltd., Sandoz, Baxter International, OMRON Healthcare Europe B.V, Propeller Health, Adherium and others.

Respiratory Inhalers Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Respiratory Inhalers Market Portraiture
2.2. Global Respiratory Inhalers Market, by Type, 2016 (US$ Mn)
2.3. Global Respiratory Inhalers Market, by Application, 2016 (US$ Mn)
2.4. Global Respiratory Inhalers Market, by Technology, 2016 (US$ Mn)
2.5. Global Respiratory Inhalers Market Share, by Geography, 2016 vs. 2025 (Value %)

Chapter 3. Global Respiratory Inhalers Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Respiratory Inhalers: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Type, 2016
4.2. Dry powder Inhalers
4.3. Metered Dose Inhalers
4.3.1. Pressurized
4.3.2. Breath-actuated
4.3.3. Non-pressurized
4.4. Nebulizers
4.4.1. Jet nebulizer
4.4.2. Mesh nebulizer
4.4.3. Ultrasonic nebulizer

Chapter 5. Global Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Application, 2016
5.2. Asthma
5.3. Chronic Obstructive Pulmonary Disorder
5.4. Pulmonary Arterial Hypertension
5.5. Cystic Fibrosis
5.6. Others

Chapter 6. Global Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Technology, 2016
6.2. Digital
6.3. Manual

Chapter 7. Global Respiratory Inhalers Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Respiratory Inhalers Market Analysis, 2015 – 2025
7.2.1. North America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.2.3. North America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.2.4. North America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Respiratory Inhalers Market Analysis, 2015 – 2025
7.3.1. Europe Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.3.3. Europe Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.3.4. Europe Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Respiratory Inhalers Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America Respiratory Inhalers Market Analysis, 2015 – 2025
7.5.1. Latin America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Mexico
7.5.4.2. Brazil
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Respiratory Inhalers Market Analysis, 2015 – 2025
7.6.1. MEA Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.6.3. MEA Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.6.4. MEA Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Adherium
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Astra Zeneca plc
8.3. Beximco Pharmaceuticals Ltd.
8.4. Boehringer Ingelheim GmbH
8.5. Cipla Inc.
8.6. GlaxoSmithKline plc
8.7. Merck & Co., Inc.
8.8. OMRON Healthcare Europe B.V
8.9. PARI Medical Holding
8.10. Propeller Health
8.11. Sandoz, Baxter International
8.12. Teva Pharmaceutical Industries Ltd.

List Of Table :

TABLE 1 Global Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Respiratory Inhalers Market, by Application, 2016 (US$ Mn)
TABLE 3 Global Respiratory Inhalers Market, by Technology, 2016 (US$ Mn)
TABLE 4 Global Respiratory Inhalers Market Share, by Geography, 2015 – 2025 (Value %)
TABLE 5 North America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 7 North America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East And Africa Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East And Africa Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East And Africa Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East And Africa Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 25 Adherium: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Astra Zeneca: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Beximco Pharmaceuticals Ltd. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cipla Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Merck & Co., Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 OMRON Healthcare Europe B.V: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 PARI Medical Holding: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Sandoz, Baxter International: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Teva Pharmaceutical Industries Ltd. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Respiratory Inhalers: Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global Dry Powder Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 5 Global Pressurized Metered Dose Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 6 Global Breath-actuated Metered Dose Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 7 Global Non-Pressurized Metered Dose Inhalers Market in Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 8 Global Jet Nebulizer Market in Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 9 Global Mesh Nebulizer Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 10 Global Ultrasonic Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 11 Global Asthma Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 12 Global Chronic Obstructive Pulmonary Disorder Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 13 Global Pulmonary Arterial Hypertension Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 14 Global Cystic Fibrosis Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Applications Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 16 Global Digital Inhalers Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 17 Global Manual Inhalers Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 18 U.S. Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 19 Canada Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 20 U.K. Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 21 Germany Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Europe Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 23 Japan Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 24 China Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest Of Asia Pacific Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 26 Mexico Digital Therapeutic Market 2015-2025 (US$ Mn)
FIG. 27 Brazil Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 28 Rest of Latin America Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 29 GCC Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 30 Rest of MEA Respiratory Inhalers Market 2015-2025 (US$ Mn)

Based on type, the global respiratory inhalers market is segmented as follows:

  • Dry powder Inhalers
  • Metered Dose Inhalers
    • Pressurized
    • Breath-actuated
    • Non-pressurized
  • Nebulizers
    • Jet nebulizer
    • Mesh nebulizer
    • Ultrasonic nebulizer

Respiratory inhalers are the most widely used dosage forms to treat mild to severe respiratory conditions. The respiratory inhalers market comprises of varied kind of inhalers such as the dry powder inhalers, metered dose inhalers and nebulizers which are prescribed based on severity of the condition and the medication used. Among the aforementioned inhaler types metered dose inhalers encapsulated larger share in the respiratory inhaler market and would continue its dominance through the forecast period. These devices are readily portable and can be used among patient suffering from all kinds of respiratory conditions as it does not require a deep breath while inhalation, thus there arises an increase in demand for these products.

Dry powder inhalers are comparatively less expensive but it requires precautions to be taken while handling the medication. Dry powder inhalers comprise of capsules which are moisture sensitive thus high humidity could affect the medication. These inhalers require a deep and fast breath to be taken which could be difficult for certain patients suffering from severe respiratory conditions.

Nebulizers are widely used for pediatric patients as they are easy to administer in infants. Nebulizers are less efficacious than metered dose inhalers as some of the medication remains back on the nebulizer device thus administering lesser dose than required. Technological advancements that are emerging to deliver medication efficaciously would drive nebulizers market to grow during the forecast period.

Respiratory Inhalers Market

Based on application, the global respiratory inhalers market is segmented as follows:

  • Asthma
  • Chronic Obstructive Pulmonary Disorder
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • Others (acute bronchitis, pneumonia, influenza)

Respiratory inhalers are used for administration of medication for respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, cystic fibrosis and other respiratory diseases. Of the above mentioned respiratory conditions COPD holds a predominant positions in respiratory inhalers market. As per the World Health Organization COPD had a prevalence of 251 million patients globally in the year 2016. This number is expected to rise further in the forecast period. According to WHO, COPD would be the third main cause of deaths by the year 2030. Thus this segment is expected to show remunerative growth in the forecast period. Additionally, COPD treatment presently incorporated combination therapy which is more efficacious and thus contributing further to the growth of respiratory inhalers market. Asthma held the second position in the global respiratory inhalers market. It is most widely prevalent condition with no permanent cure but therapies provide symptomatic relief when required. Respiratory inhalers are predominantly used for medication thus this segment would contribute to the lucrative growth of respiratory inhalers market during the forecast period.

Respiratory Inhalers Market

Based on technology, the global respiratory inhalers market is segmented as follows:

  • Digital
  • Manual

Manual respiratory inhalers currently dominate the market as it is widely available and affordable across geographies. The digital segment is expected to grow in the forecast period owing to the emergence of smart inhalers into the market. Digital inhalers enable the recovery of real time data which could be recovered at any point of time. For example Adherium’s smart touch inhaler integrated with bluetooth facility has entered the market along with AstraZeneca’s drug Symbicort aerosol inhaler. Moreover, the collaboration of Propeller Health and Novartis to develop a dry powder inhaler has also contributed to the growth of this market. The device comprises of an add-on sensor that would provide dosage data which can be easily monitored would provide better patient adherence and would help enable remote monitoring of patients. These advancements are creating demand for the respiratory inhalers, increasing patient adherence and thus the digital segment is projected to show remunerative growth during the forecast period, 2017-2025. Furthermore, the development of a structured digital reimbursement policy for chronic conditions is expected to propel the demand for smart inhalers in the future.

Respiratory Inhalers Market

For the purpose of this study, the global respiratory inhalers market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Respiratory Inhalers Market

The respiratory inhalers have a vast outreach and is available across all geographies. North America held the leading position in the respiratory inhalers market. The availability of respiratory inhalers, presence of leading industries in this region, higher economic status of patients and constant development of digital health reimbursement policy are the catalysts that drive this market. The Centers for Medicare and Medicaid Services (CMS) is providing various solutions to organizations to provide reimbursement options for managing chronic conditions with non-face-to-face monitoring patients such as asthma and COPD. Asia Pacific is expected to be the fastest growing market for respiratory inhalers owing to a high prevalence of respiratory conditions such as asthma and COPD. The World Health Organization (WHO) states that 80% of deaths occur in the low and middle income economies. The constant rise in industrialization leading to increase in pollution has also increased the risk of acquiring respiratory diseases thus having a positive impact on the respiratory inhaler market in Asia Pacific during the forecast period, 2017-2025.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients